1-15 of 29
The IL-36 Connection: Immunology’s Role in GPP Pathogenesis and Therapy
CME/CEThe IL-36 Connection: Immunology’s Role in GPP Pathogenesis and Therapy
Anthony Fernandez, MD, PhD
Sjögren’s Myth Busters: Can You Detect Fact from Fiction on Emerging Therapies?
CME/CESjögren’s Myth Busters: Can You Detect Fact from Fiction on Emerging Therapies?
Chadwick R. Johr, MD
Diagnostic Challenges in Refractory Chronic Cough: From Burden to Solutions
CME/CEDiagnostic Challenges in Refractory Chronic Cough: From Burden to Solutions
Sandhya Khurana, MD, FCCP
Syed Shahzad Mustafa, MD
Ashley Wilk, DO, DipABLM
Case Challenges in Systemic Mastocytosis: Clinical Insights From the Expert Roundtable
CME/CECase Challenges in Systemic Mastocytosis: Clinical Insights From the Expert Roundtable
Carole Bitar, MD, FAAD
Matthew P. Giannetti, MD
Benjamin Ungar, MD
Living With Systemic Mastocytosis: Bridging Clinical Decisions and Patient Realities
CME/CELiving With Systemic Mastocytosis: Bridging Clinical Decisions and Patient Realities
Cem Akin, MD, PhD
A Seat at the HS Expert’s Table: A Master Class in Diagnosis and Treatment Advances for Hidradenitis Suppurativa
CME/CEA Seat at the HS Expert’s Table: A Master Class in Diagnosis and Treatment Advances for Hidradenitis Suppurativa
Leandra A. Barnes, MD
Mikael Horissian, MD, MBA
Katrina H. Lee, MD
Venessa Peña-Robichaux, MD
- advertisement
Navigating Today and Shaping Tomorrow in ISM: Personalized Strategies With Current and Emerging KIT Inhibitors
CME/CENavigating Today and Shaping Tomorrow in ISM: Personalized Strategies With Current and Emerging KIT Inhibitors
Mariana C. Castells, MD, PhD
Tsewang Tashi, MD
Test Your Skills and Learn From Experts on Best Practice in Diagnosis and Management of Systemic Mastocytosis
CME/CETest Your Skills and Learn From Experts on Best Practice in Diagnosis and Management of Systemic Mastocytosis
Carole Bitar, MD, FAAD
Matthew P. Giannetti, MD
Benjamin Ungar, MD
Hitting the Target in Atopic Dermatitis: Interdisciplinary Team Training for Leveraging IL-13 Inhibitors to Address the Burden of Disease
CME/CEHitting the Target in Atopic Dermatitis: Interdisciplinary Team Training for Leveraging IL-13 Inhibitors to Address the Burden of Disease
Anne Marie Singh, MD
Decoding EGPA: A Clinical Deep Dive Into Diagnosis and Treatment
CME/CEDecoding EGPA: A Clinical Deep Dive Into Diagnosis and Treatment
Praveen Akuthota, MD
Anisha Dua, MD, MPH
Michael E. Wechsler, MD, MMSc
Future-Proofing in HAE: Advances in Long-term Prophylaxis to Prevent Attacks and Improve Quality of Life
CME/CEFuture-Proofing in HAE: Advances in Long-term Prophylaxis to Prevent Attacks and Improve Quality of Life
Marc A. Riedl, MD, MS
Pruritus In PN and AD: Challenge How You Manage Itch
CME/CEPruritus In PN and AD: Challenge How You Manage Itch
Peter A. Lio, MD
- advertisement
Current & Emerging Therapies: Treating & Preventing Hereditary Angioedema Attacks in Children & Adults
CME/CECurrent & Emerging Therapies: Treating & Preventing Hereditary Angioedema Attacks in Children & Adults
Marc A. Riedl, MD, MS
Test Your Skills and Learn From Experts on IL-13 Inhibitors in Moderate to Severe Atopic Dermatitis
CME/CETest Your Skills and Learn From Experts on IL-13 Inhibitors in Moderate to Severe Atopic Dermatitis
Andrew F. Alexis, MD, MPH
Daniel C. Butler, MD
Shawn G. Kwatra, MD
Collaborative Care for CRSwNP Expert and Patient Insights
CME/CECollaborative Care for CRSwNP Expert and Patient Insights
Stella Lee, MD
Katie Buchheit, MD
Michael E. Wechsler, MD, MMSc
